Clinical Studies

Evaluating the Clinical Impact of Lipomac™: Insights into Bioavailability

Objective: To compare the bioavailability of Lipomac™ —our Liposomal Vitamin C formulation—against a non-liposomal Vitamin C supplement in healthy adult volunteers.

Study Details:

• Participants: 12 healthy adults
• Test Product: Lipomac™ (Liposomal Vitamin C) – 500mg (2 capsules per day)
• Reference Product: Non-Liposomal Vitamin C – 500mg (2 capsules per day)
• Administration: Oral intake of 500mg (2 capsules per day)

Results: The study assessed the safety and pharmacokinetic parameters to determine the bioavailability of Lipomac™. Findings revealed that Lipomac™ offers significantly enhanced bioavailability compared to the non-liposomal Vitamin C. Specifically, Lipomac™ demonstrated superior absorption, with bioavailability approximately 2.36 times higher than that of the non-liposomal Vitamin C.